We are live on
!
Find out more
SI
Scharf Investments Portfolio holdings
AUM
$3.03B
1-Year Est. Return
7.75%
This Fund
S&P 500
This Quarter
Est. Return
-0.8%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$3.72B
AUM Growth
-$255M
(-6.4%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
45.67%
Holding
78
New
9
Increased
14
Reduced
43
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$99.7M |
| 2 |
MRSH
Marsh
MRSH
|
+$66.9M |
| 3 |
Booking.com
BKNG
|
+$57.4M |
| 4 |
UnitedHealth
UNH
|
+$48.5M |
| 5 |
Zoetis
ZTS
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$93.5M |
| 2 |
Comcast
CMCSA
|
+$68.2M |
| 3 |
McKesson
MCK
|
+$48.1M |
| 4 |
Donaldson
DCI
|
+$43.3M |
| 5 |
Novartis
NVS
|
+$32.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.67% |
| 2 | Healthcare | 22.42% |
| 3 | Industrials | 11.46% |
| 4 | Technology | 10.27% |
| 5 | Communication Services | 5.45% |
Similar funds
MCM
CM
JIC
MB
CFM
SM
TAM
KIA
Scharf Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Scharf Investments held 78 positions worth $3.72B, down 6.4% from $3.98B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Scharf Investments withdrew a net $156M in Q4 2025, closing 6 positions and reducing 43 holdings. Its most notable exit was AstraZeneca, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Scharf Investments opened a new position in Marsh worth $66.4M.
- Scharf Investments's largest Q4 2025 buy was Marsh: 357,764 shares worth $66.4M.
- Scharf Investments added most to Meta Platforms (Facebook) in Q4 2025, an estimated $99.7M increase.
- Scharf Investments's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $93.5M.
- Scharf Investments fully exited AstraZeneca in Q4 2025, selling an estimated $7.09M.
- Scharf Investments's ten largest holdings make up 46% of its $3.72B portfolio in Q4 2025.
- Scharf Investments opened 9 new positions and closed 6 in Q4 2025.
- Scharf Investments's portfolio value fell 6.4% quarter-over-quarter to $3.72B.
Based on Scharf Investments's 13F filing for Q4 2025, filed 15 Jan 2026.